ArticleJournal of cellular and molecular medicine2025
The Mechanism Exploration of Traditional Chinese Medicine's "Different Treatments for Same Disease" Concept in Osteoporosis Therapy: A Serum Metabolomics Study.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Berberine Attenuates Glucocorticoid-Induced Bone Loss in Mice: Associated with the Gut Microbiota-Glycerophospholipid Metabolic Axis.Foods (Basel, Switzerland) · 2026Article
- The Mechanism Exploration of Traditional Chinese Medicine's "Different Treatments for Same Disease" Concept in Osteoporosis Therapy: A Serum Metabolomics Study.Journal of cellular and molecular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The "different treatments for same disease" is an important concept of traditional Chinese medicine (TCM) therapy. In TCM, osteoporosis (OP) treatment is aimed at invigorating blood, strengthening spleen, and tonifying kidneys, and their typical herbs are Angelica sinensis (Oliv.) Diels (Danggui, DG), Poria cocos (Schw.) Wolf (Fuling, FL), and Achyranthes bidentata Blume (Niuxi, NX). Nevertheless, molecular mechanisms of these different therapies of OP under the concept of "different treatments for same disease" are still unclear. The objective of this study was to identify the related metabolites and biological processes in these three distinct therapeutic approaches for osteoporosis, by using serum metabolomics analysis. A model of postmenopausal OP (PMOP) was created using bilateral ovariectomized rats and then administered with DG, FL, or NX for 12 weeks. To assess the efficacy of the three treatments, we performed gross pathology evaluation, micro-computed tomography (micro-CT) scan, bone-strength test, and histopathologic examination. The results demonstrated that the treatment groups improved weight, rectal temperature, and 24-h urine output when compared to the model group. Furthermore, the PMOP models exhibited significant increases in bone strength, bone mass, and physical bone parameters after three distinct treatments. Serum metabolomics analysis subsequently showed that DG was predominantly associated with glycerophospholipids, prenol lipids, and steroid lipid metabolism. FL was primarily linked to glycerophospholipid and amino acid metabolism. The primary metabolisms associated with NX include sphingolipid, glycerophospholipid, amino acid, and purine metabolisms. In conclusion, the DG, FL, and NX herbs effectively alleviate PMOP by regulating lipid metabolism, while FL is also involved in amino acid metabolism and NX in amino acid and purine metabolisms. Our results provide biological evidence for the TCM principle of "different treatments for same disease".
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.